• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

功能性重组大鼠过敏毒素C5a的核苷酸序列及校正后的氨基酸序列。

Nucleotide and corrected amino acid sequence of the functional recombinant rat anaphylatoxin C5a.

作者信息

Rothermel E, Rolf O, Götze O, Zwirner J

机构信息

Abteilung für Immunologie, Universität Gottingen, Germany.

出版信息

Biochim Biophys Acta. 1997 Mar 20;1351(1-2):9-12. doi: 10.1016/s0167-4781(97)00006-7.

DOI:10.1016/s0167-4781(97)00006-7
PMID:9116048
Abstract

For bacterial expression of rat anaphylatoxin C5a, the cDNA was amplified by reverse transcriptase-polymerase chain reaction (RT-PCR) using rat liver RNA and degenerate primers designed according to the published amino acid sequence [1]. Surprisingly, the amino acid sequence deduced from cDNA differed at positions 55 (N for K), 63 (K for H), 67 (E for N), 68 (S for E) and 69 (H for S) from the published sequence. The overall amino acid composition, however, was unchanged because these 5 amino acids were located at different positions compared to the published sequence. As a consequence, the proposed N-glycosylation site was absent, suggesting O-glycosylation of the mature molecule. Recombinant rat C5a with a 6 histidine tag at the N-terminus was expressed in bacteria, purified and renatured. The peptide was as potent as recombinant human C5a in eliciting lysosomal enzyme release from human granulocytes.

摘要

为了在细菌中表达大鼠过敏毒素C5a,使用大鼠肝脏RNA和根据已发表的氨基酸序列设计的简并引物,通过逆转录聚合酶链反应(RT-PCR)扩增cDNA[1]。令人惊讶的是,从cDNA推导的氨基酸序列在第55位(K被N取代)、63位(H被K取代)、67位(N被E取代)、68位(E被S取代)和69位(S被H取代)与已发表序列不同。然而,总体氨基酸组成未变,因为与已发表序列相比,这5个氨基酸位于不同位置。因此,推测的N-糖基化位点不存在,提示成熟分子进行O-糖基化。在细菌中表达、纯化并复性了在N端带有6个组氨酸标签的重组大鼠C5a。该肽在诱导人粒细胞释放溶酶体酶方面与重组人C5a一样有效。

相似文献

1
Nucleotide and corrected amino acid sequence of the functional recombinant rat anaphylatoxin C5a.功能性重组大鼠过敏毒素C5a的核苷酸序列及校正后的氨基酸序列。
Biochim Biophys Acta. 1997 Mar 20;1351(1-2):9-12. doi: 10.1016/s0167-4781(97)00006-7.
2
A recombinant hybrid anaphylatoxin with dual C3a/C5a activity.一种具有双重C3a/C5a活性的重组杂合过敏毒素。
Biochem J. 1992 Nov 15;288 ( Pt 1)(Pt 1):261-6. doi: 10.1042/bj2880261.
3
Site-specific mutagenesis of residues in the human C5a anaphylatoxin which are involved in possible interaction with the C5a receptor.对人C5a过敏毒素中可能参与与C5a受体相互作用的残基进行位点特异性诱变。
Eur J Biochem. 1994 Feb 1;219(3):897-904. doi: 10.1111/j.1432-1033.1994.tb18571.x.
4
C5a mutants are potent antagonists of the C5a receptor (CD88) and of C5L2: position 69 is the locus that determines agonism or antagonism.C5a突变体是C5a受体(CD88)和C5L2的强效拮抗剂:第69位是决定激动作用或拮抗作用的位点。
J Biol Chem. 2004 Jan 2;279(1):142-51. doi: 10.1074/jbc.M310078200. Epub 2003 Oct 21.
5
Primary structure and functional characterization of rat C5a: an anaphylatoxin with unusually high potency.大鼠C5a的一级结构及功能特性:一种具有异常高效力的过敏毒素。
Protein Sci. 1994 Aug;3(8):1169-77. doi: 10.1002/pro.5560030803.
6
Expression cloning of a receptor for C5a anaphylatoxin on differentiated HL-60 cells.
Biochemistry. 1991 Mar 26;30(12):2993-9. doi: 10.1021/bi00226a002.
7
Differential expression of the C5a receptor on the main cell types of rat liver as demonstrated with a novel monoclonal antibody and by C5a anaphylatoxin-induced Ca2+ release.用一种新型单克隆抗体及C5a过敏毒素诱导的钙离子释放所证实的大鼠肝脏主要细胞类型上C5a受体的差异表达。
Lab Invest. 1999 Oct;79(10):1287-97.
8
Cloning and functional expression of the canine anaphylatoxin C5a receptor. Evidence for high interspecies variability.犬过敏毒素C5a受体的克隆与功能表达。种间高度变异性的证据。
Biochem J. 1992 Dec 15;288 ( Pt 3)(Pt 3):911-7. doi: 10.1042/bj2880911.
9
Human C5a anaphylatoxin: gene cloning and expression in Escherichia coli.
Immunobiology. 1992 Jun;185(1):41-52. doi: 10.1016/S0171-2985(11)80316-5.
10
Human C5a anaphylatoxin: gene synthesis, expression, and recovery of biologically active material from Escherichia coli.
Methods Enzymol. 1988;162:653-68. doi: 10.1016/0076-6879(88)62107-0.